** Genetic testing company GeneDx WGS.O shares slump 41.5% to $68.43 and set for biggest one-day fall on record
** Co posts Q1 rev of $87.1 mln, down 8.6% from last quarter's $95.3 mln
** Reports net loss of $6.5 mln, or 23 cents per share, in Q1
** WGS, however, beats analysts' estimates for Q1 results and forecasts full-year revenue above estimates- LSEG data
** Three out of 6 analysts rate stock as "buy" or higher, 3 "hold"; Median PT is $109.50
** At last close, WGS was trading at over two-year high of $117.75
** Including session's moves, WGS down ~11% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。